SEC Form 4 · accession 0001225208-15-017321
Cigna Holding Co · CI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Herbert A Fritch
Officer — President, HealthSpring
Period of report
Aug 17, 2015
Accepted (ET)
Aug 19, 2015 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000701221
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.25 Par Value | Aug 17, 2015 | M | 14,534 | $14.40 | A | 304,542 | D | |
| Common Stock, $.25 Par Value | Aug 17, 2015 | M | 12,235 | $30.13 | A | 316,777 | D | |
| Common Stock, $.25 Par ValueF2 | Aug 17, 2015 | S | 7,882 | $144.7975 | D | 308,895 | D | |
| Common Stock, $.25 Par ValueF3 | Aug 17, 2015 | S | 13,187 | $145.4939 | D | 295,708 | D | |
| Common Stock, $.25 Par ValueF4 | Aug 17, 2015 | S | 17,420 | $143.3013 | D | 278,288 | D | |
| Common Stock, $.25 Par Value | Aug 18, 2015 | M | 5,042 | $14.40 | A | 283,330 | D | |
| Common Stock, $.25 Par Value | Aug 18, 2015 | M | 3,579 | $30.13 | A | 286,909 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F5 | $14.40 | Aug 17, 2015 | M | 14,534 | D | — | Feb 11, 2020 | Common Stock, $.25 Par Value | 14,534 | 143,794 | D |
| Employee Stock Option (Right to Buy)F6 | $30.13 | Aug 17, 2015 | M | 12,235 | D | — | Mar 7, 2021 | Common Stock, $.25 Par Value | 12,235 | 167,747 | D |
| Employee Stock Option (Right to Buy)F5 | $14.40 | Aug 18, 2015 | M | 5,042 | D | — | Feb 11, 2020 | Common Stock, $.25 Par Value | 5,042 | 138,752 | D |
| Employee Stock Option (Right to Buy)F6 | $30.13 | Aug 18, 2015 | M | 3,579 | D | — | Mar 7, 2021 | Common Stock, $.25 Par Value | 3,579 | 164,168 | D |
Explanation of responses
- F1These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2014.
- F2Represents the weighted average price of the shares sold. The prices actually received ranged from $144.14 to $145.11 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F3Represents the weighted average price of the shares sold. The prices actually received ranged from $145.17 to $145.73 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F4Represents the weighted average price of the shares sold. The prices actually received ranged from $143.00 to $143.81 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F5This option vested as follows: 50% on February 11, 2012, 25% on February 11, 2013 and 25% on February 11, 2014.
- F6This option vested as follows: 50% on March 7, 2013, 25% on March 7, 2014 and 25% on March 7, 2015.